p16<sup>Ink4a</sup> and p21<sup>Cip1/Waf1</sup> promote tumour growth by enhancing myeloid-derived suppressor cells chemotaxis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29234059.
- Also identified by DOI 10.1038/s41467-017-02281-x and PMC identifier 5727112.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
p16<sup>Ink4a</sup> and p21<sup>Cip1/Waf1</sup> act as tumour suppressors through induction of cellular senescence. However, senescence-independent roles of these CDK inhibitors are not well understood. Here, we report an unexpected function of p16<sup>Ink4</sup> and p21<sup>Cip1/Waf1</sup>, namely, tumour promotion through chemotaxis. In monocytic myeloid-derived suppressor cells (Mo-MDSCs), p16<sup>Ink4</sup> and p21<sup>Cip1/Waf1</sup> are highly expressed and stimulate CX3CR1 chemokine receptor expression by preventing CDK-mediated phosphorylation and inactivation of SMAD3. Thus, deletion of p16 <sup>Ink4</sup> and p21 <sup>Cip1/Waf1</sup> reduces CX3CR1 expression, thereby inhibiting Mo-MDSC accumulation in tumours expressing CX3CL1 and suppressing the tumour progression in mice. Notably, blockade of the CX3CL1/CX3CR1 axis suppresses tumour growth, whereas inactivation of CDKs elicits the opposite effect. These findings reveal an unexpected function of p16 <sup>Ink4a</sup> and p21 <sup>Waf1/Cip1</sup> and indicate that regulation of Mo-MDSCs chemotaxis is a valuable potential strategy for control of tumour development.
Medical subject headings
- Chemotaxis
- Cyclin-Dependent Kinase Inhibitor p16
- Cyclin-Dependent Kinase Inhibitor p21
- Myeloid-Derived Suppressor Cells
- Neoplasms